Page last updated: 2024-08-23

daunorubicin and Angiogenesis, Pathologic

daunorubicin has been researched along with Angiogenesis, Pathologic in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (42.86)	29.6817
2010's	4 (57.14)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Binner, M; Bornhäuser, M; Bray, LJ; Körner, Y; von Bonin, M; Werner, C	1
Cheng, L; Ju, RJ; Li, CQ; Li, XT; Liu, S; Peng, XM; Qiu, X; Song, XL; Wang, T	1
Gacs, A; Hegedüs, R; Kapuvári, B; Manea, M; Mező, G; Schulcz, Á; Tóvári, J; Vincze, B	1
Chow, MS; Hao, J; Huang, Y; Lam, CW; Lau, B; Liu, M; Ravula, R; Shi, L; Song, Y; Wang, J; Wang, Z; Yeung, S	1
Belleri, M; Presta, M; Ribatti, D; Vacca, A	1
Albitar, M; Andreeff, M; Cortes, J; Estey, E; Faderl, S; Garcia-Manero, G; Giles, F; Kantarjian, H; Keating, M; Koller, C; O'Brien, S; Thomas, D	1
Do, DV; Han, HC; Khoo, YT; Lim, IJ; Mukhopadhyay, A; Ong, CT; Phan, TT; Tan, EK	1

Trials

1 trial(s) available for daunorubicin and Angiogenesis, Pathologic

Article	Year
A randomized trial of liposomal daunorubicin and cytarabine versus liposomal daunorubicin and topotecan with or without thalidomide as initial therapy for patients with poor prognosis acute myelogenous leukemia or myelodysplastic syndrome. Cancer, 2003, Mar-01, Volume: 97, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Endothelial Growth Factors; Humans; Intercellular Signaling Peptides and Proteins; Leukemia, Myeloid, Acute; Liposomes; Lymphokines; Middle Aged; Myelodysplastic Syndromes; Neovascularization, Pathologic; Prognosis; Survival Analysis; Thalidomide; Topotecan; Treatment Outcome; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors	2003

Article

Year

A randomized trial of liposomal daunorubicin and cytarabine versus liposomal daunorubicin and topotecan with or without thalidomide as initial therapy for patients with poor prognosis acute myelogenous leukemia or myelodysplastic syndrome.

Cancer, 2003, Mar-01, Volume: 97, Issue:5

Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Endothelial Growth Factors; Humans; Intercellular Signaling Peptides and Proteins; Leukemia, Myeloid, Acute; Liposomes; Lymphokines; Middle Aged; Myelodysplastic Syndromes; Neovascularization, Pathologic; Prognosis; Survival Analysis; Thalidomide; Topotecan; Treatment Outcome; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors

2003

Other Studies

6 other study(ies) available for daunorubicin and Angiogenesis, Pathologic

Article	Year
A three-dimensional Haematologica, 2017, Volume: 102, Issue:7 Topics: Benzylamines; Biomarkers; Cell Communication; Cell Culture Techniques; Cell Line, Tumor; Cell Movement; Cyclams; Cytarabine; Daunorubicin; Drug Resistance, Neoplasm; Drug Synergism; Heterocyclic Compounds; Humans; Immunophenotyping; Leukemia, Myeloid, Acute; Neovascularization, Pathologic; Receptors, CXCR4; Spheroids, Cellular; Tumor Cells, Cultured; Tumor Microenvironment	2017
Hyaluronic acid modified daunorubicin plus honokiol cationic liposomes for the treatment of breast cancer along with the elimination vasculogenic mimicry channels. Journal of drug targeting, 2018, Volume: 26, Issue:9 Topics: Animals; Biphenyl Compounds; Breast Neoplasms; Cations; Daunorubicin; Female; Humans; Hyaluronic Acid; Lignans; Liposomes; MCF-7 Cells; Mice; Neovascularization, Pathologic	2018
Improved in vivo antitumor effect of a daunorubicin - GnRH-III bioconjugate modified by apoptosis inducing agent butyric acid on colorectal carcinoma bearing mice. Investigational new drugs, 2016, Volume: 34, Issue:4 Topics: Animals; Antibiotics, Antineoplastic; Butyric Acid; Cell Proliferation; Colorectal Neoplasms; Daunorubicin; Female; Gonadotropin-Releasing Hormone; Heart; HT29 Cells; Humans; Liver; Male; Mice; Neovascularization, Pathologic; Pyrrolidonecarboxylic Acid; Tumor Burden; Xenograft Model Antitumor Assays	2016
Overcoming chemoresistance in prostate cancer with Chinese medicine Tripterygium wilfordii via multiple mechanisms. Oncotarget, 2016, 09-20, Volume: 7, Issue:38 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Caco-2 Cells; Cell Cycle; Cell Line, Tumor; Cell Survival; Daunorubicin; Docetaxel; Drug Resistance, Neoplasm; Drugs, Chinese Herbal; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Inhibitory Concentration 50; Male; Mice; Mice, SCID; Neoplasm Transplantation; Neovascularization, Pathologic; Plant Extracts; Prostatic Neoplasms; Taxoids; Tripterygium	2016
Anti-angiogenic activity of the purine analog 6-thioguanine. Leukemia, 2002, Volume: 16, Issue:8 Topics: 2-Aminopurine; Acute Disease; Aged; Allantois; Anemia; Angiogenesis Inhibitors; Animals; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cattle; Cell Line, Transformed; Chick Embryo; Chorion; Cytarabine; Daunorubicin; Drug Evaluation; Endothelial Growth Factors; Endothelium, Vascular; Etoposide; Female; Fibroblast Growth Factor 2; Follow-Up Studies; Humans; Leukemia, Myeloid; Lymphokines; Male; Mice; Mice, Inbred BALB C; Middle Aged; Neovascularization, Pathologic; Neovascularization, Physiologic; Remission Induction; Stress, Mechanical; Thioguanine; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors	2002
Epithelial-mesenchymal interactions in keloid pathogenesis modulate vascular endothelial growth factor expression and secretion. The Journal of pathology, 2007, Volume: 211, Issue:1 Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Cell Differentiation; Cell Proliferation; Coculture Techniques; Culture Media, Conditioned; Daunorubicin; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Epithelial Cells; Fibroblasts; Humans; Immunohistochemistry; Keloid; Keratinocytes; Mesoderm; Mitoxantrone; Neovascularization, Pathologic; Sirolimus; Statistics, Nonparametric; Up-Regulation; Vascular Endothelial Growth Factor A; Wound Healing	2007